Hyperphosphatemia as a potential risk factor for arteriovenous fistula dysfunction: A retrospective study in hemodialysis patients
PLOS One · 2025
DOI: 10.1371/journal.pone.0335599 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Yujie Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Hyperphosphatemia, Renal Dialysis, Arteriovenous Fistula, Arteriovenous Shunt, Surgical. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The study investigates the relationship between Hyperphosphatemia and arteriovenous fistula dysfunction in patients undergoing maintenance hemodialysis.
Methods
Data were collected from patients who had their first arteriovenous fistula creation and regular maintenance hemodialysis between 2019 and 2023. Patients were divided into four groups based on serum phosphorus levels ( 1.965 mmol/L). Statistical methods included Kaplan-Meier survival curves, Cox proportional hazards regression models, and Restricted Cubic Spline.
Results
The study included 239 patients. Kaplan-Meier survival curves showed that Hyperphosphatemia significantly correlated with arteriovenous fistula dysfunction (P = 0.0052). Cox univariate analysis showed phosphorus (HR = 3.16, P < 0.001) is risk factor of arteriovenous fistula dysfuntion. Multivariate Cox regression analysis further confirmed high phosphorus levels were an independent risk factor of AVF dysfuntion (P for trend
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China.
- Department of Nephrology, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China.
ORCID-Profile: Yujie Jiang, Shoulin Zhang
Zitieren
APA
Jiang, Y., Cui, C., Nan, H., Chang, T., Li, F., & Zhang, S. (2025). Hyperphosphatemia as a potential risk factor for arteriovenous fistula dysfunction: A retrospective study in hemodialysis patients. PLOS One. https://doi.org/10.1371/journal.pone.0335599
Vancouver
Jiang Y, Cui C, Nan H, Chang T, Li F, Zhang S. Hyperphosphatemia as a potential risk factor for arteriovenous fistula dysfunction: A retrospective study in hemodialysis patients. PLOS One. 2025. doi:10.1371/journal.pone.0335599
BibTeX
@article{Jiang2025,
author = {Jiang, Yujie and Cui, Chengji and Nan, He and Chang, Tianying and Li, Fan and Zhang, Shoulin},
title = {Hyperphosphatemia as a potential risk factor for arteriovenous fistula dysfunction: A retrospective study in hemodialysis patients},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0335599}
}
EUVIMED